Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3 + 4 Favorable Intermediate-risk Prostate Cancer

David D. Yang, Brandon A. Mahal, Vinayak Muralidhar, Michelle D. Nezolosky, Marie E. Vastola, Shelby A. Labe, Ninjin Boldbaatar, Martin T. King, Neil E. Martin, Peter F. Orio, Clair J. Beard, Karen E. Hoffman, Quoc Dien Trinh, Daniel E. Spratt, Felix Y. Feng, Paul L. Nguyen

Research output: Contribution to journal › Article › peer-review

40 Scopus citations

Fingerprint

Dive into the research topics of 'Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3 + 4 Favorable Intermediate-risk Prostate Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences